AI For Pharma Growth

Episodes

E211: Precision Monitoring: How Digital Biomarkers Are Changing Medicine

March 31, 2026

AI-powered digital biomarkers are personalizing medicine by turning wearables into continuous monitors for diseases like Duchenne's.

E210: Beyond Alzheimer’s: Scaling Digital Twins Across Disease Areas

March 25, 2026

Unlearn.ai's Aaron Smith discusses scaling generative AI digital twins beyond Alzheimer's to enhance clinical trials across diverse disease areas.

E209: Beyond Failure Prevention: How AI is Redesigning the Drug Discovery Pipeline

March 18, 2026

AI is shifting from failure prevention to proactively redesigning drug discovery by unifying siloed biological data for novel breakthroughs.

E208 : The future of enterprise AI: agents, automation, and trust

March 11, 2026

Enterprise AI is now mission-critical. Success with AI agents hinges on establishing trust through foundational data governance and auditability.

Ep207: The economics of clinical trials and the relationship to AI

March 4, 2026

AI is reshaping clinical trial economics by finding patient subpopulations to reveal a drug's superpower, slashing high failure rates and costs.

EP206: Why Your Pharma AI Strategy Is Probably Broken — And What a Real Blueprint Looks Like

February 25, 2026

Most pharma AI strategies fail. Dr. Bates reveals why they're broken and how a business-first, financially-modeled blueprint is essential.

Healthcare Accessibility & Innovation

February 18, 2026

AI-powered SMS is transforming healthcare by improving patient adherence, democratizing clinical trial recruitment, and boosting overall engagement.

E204: Human-Centered AI: Designing Intelligence That Aligns With Us

February 11, 2026

Making powerful AI human-centered is a choice we must make now. This episode explores how to bake human values into tech to avoid future problems.

E203: Building Programmable Biologics from Scratch: How DenovAI's AI is Revolutionizing Drug Discovery

February 4, 2026

DenovAI is using AI and physics to design programmable biologics from scratch, shifting drug discovery from a search problem to intentional design.

E202: Recent Advances in LLMs and How They Will Impact Science and Pharma Research

January 28, 2026

LLMs are revolutionizing pharma research. Javier Taudable of Pauling.ai explains how AI accelerates drug discovery and clinical trials.

E201: The Small Molecule Revolution: ProPhet's Tom Shani on AI-Powered Drug Discovery

January 21, 2026

ProPhet CEO Tom Shani on AI's revolution in small molecule discovery, tackling data issues and accelerating timelines for hard-to-drug proteins.

E200: Podcast with Cures & Capital Part 3

January 14, 2026

Dr. Andre Bates discusses AI's pharma revolution, from quick wins in regulatory affairs to a future of digital twins and preventative medicine.

E199: Podcast with Cures & Capital Part 2

January 7, 2026

Pharma's AI revolution is stalled by strategy fragmentation, not tech. Win by connecting isolated pilots into an enterprise-wide capability, led from the board.

E198: Podcast with Cures & Capital Part 1

December 31, 2025

Pharma's AI journey: Move from failing pilots to strategic, ROI-driven implementation. Expert insights on calculating value and avoiding pitfalls.

E197: Inside the AI Factory: How AI Systems Builds Workflows That Actually Work

December 24, 2025

Go inside the AI Factory to learn how to build AI workflows that deliver real results by focusing on workflow discovery and human collaboration.